Marijuana Stocks

Much like the U.S. legal status on marijuana, the verdict on marijuana stocks is still up in the air. While the bulls like to think that the marijuana industry is about to explode with their optimism over the pending decriminalization and legalization of marijuana, the bears view marijuana stocks as a very risky investment to the point that they may be scams. Marijuana Penny Stocks such as Cannabis Science Inc (CBIS) are risky due to fact that they are in a grey legal area. But as Canada’s nascent legal marijuana market blossoms, many pot stocks are worth adding to your portfolio.

Related to Marijuana Stocks:

Constellation Brands Stock Looks Even More Compelling Now

By Luke Lango, InvestorPlace Senior Investment Analyst
Data refutes the idea that cannabis sales will steal share from alcohol sales, and that means STZ stock is a buy on this recent dip.

Will Aurora Cannabis Stock Be the Next Marijuana Stock to Breakout?

By Luke Lango, InvestorPlace Senior Investment Analyst
Cowen sees ACB stock doubling over the next year. That could happen, but only after a very specific catalyst materializes for Aurora Cannabis.

What You Should Expect From Marijuana Stocks That Make the ‘Jump’

By InvestorPlace Research Staff
We've seen it several times now: Marijuana stocks that make the jump to a well-known exchange can benefit greatly from the additional attention.

Aurora Cannabis Should Have Bought This Hemp Company

By Will Ashworth, InvestorPlace Contributor
Aurora Cannabis missed a good opportunity this week to keep up with its peers, and ACB stock could suffer as a result.

3 Under-the-Radar Cannabis Stocks to Buy

By InvestorPlace Research Staff
These cannabis stocks may not be as high-profile as CGC or TLRY, but that's the point -- buy these marijuana stocks now while they're cheap!

Why Cronos Stock Isn’t Overvalued Here

By Luke Lango, InvestorPlace Senior Investment Analyst
After doubling in two months, CRON stock still isn't overvalued, but it also isn't the best pick in the cannabis space.

Don’t Stress Recent Weakness in Canopy Growth Stock

By Luke Lango, InvestorPlace Senior Investment Analyst
The recent near-10% drop in CGC stock is a healthy pullback before this stock takes its next big step forward later in 2019.

Invest Early Ahead of Business Trends

By Luis Hernandez, Editor in Chief
Individuals who want to grow wealth must get ahead of trends and invest early. Two such opportunities are becoming increasingly mainstream.

Is Canopy Growth Stock the Best Cannabis Play?

By Bret Kenwell, InvestorPlace Contributor
CGC stock has roughly doubled from its December lows to its January highs. Canopy Growth is good, but it needs time to digest that big rally.

As Cronos Stock Skyrockets, Should Investors Be Afraid?

By Chris Lau, InvestorPlace Contributor
Cronos shares have been climbing for months after Altria invested billions in the firm. Is it time to lock in CRON stock profits?

Should You Buy, Sell, Or Hold These 7 Medical Cannabis Stocks?

By Ian Bezek, InvestorPlace Contributor
With cannabis stocks on fire, medical marijuana is the place to be. Here is the latest scoop on these seven leading medicinal pot stock plays.

Is Aurora Cannabis Stock Worth a Buy on Stratospheric Sales?

By Tom Taulli, InvestorPlace Contributor
Aurora Cannabis stock investors had mixed reactions to ACB's fiscal quarter results. Here's what you need to know about the company's results.

Should You Chase the Big Rally In Pyxus Stock?

By Luke Lango, InvestorPlace Senior Investment Analyst
Pyxus stock popped more than 25% after Q3 earnings, but fundamental challenges will likely cap further upside.

Are Marijuana Stocks Generally Overvalued?

By James Brumley, InvestorPlace Feature Writer
Marijuana stocks like Aurora, Tilray and Canopy Growth have had a great past few months, but the reality is going to set in sooner or later.

Cannabis Stocks: Do Aurora or Canopy Earnings Matter?

By Dana Blankenhorn, InvestorPlace Contributor
Marijuana stocks like Aurora and Canopy Growth are highly volatile, and speculators would be to wise to buy only when they're down.

Amyris Stock Can Run Much Higher Than You Think

By Will Healy, InvestorPlace Contributor
Amyris' move into cannabis has turned AMRS stock into a marijuana equity, and hemp legalization will help propel AMRS to multi-year highs.

Why Aurora Cannabis Stock Will Be the Biggest Winner – or the Biggest Loser – in Pot

By Vince Martin, InvestorPlace Contributor
Aurora Cannabis stock has risen nicely in 2019. But longer-term, ACB stock is likely to be either a big winner or a big loser.

It’s Time for Cronos Stock to Dive Back Down to Reality

By Tim Biggam, InvestorPlace Contributor
The CRON stock price has gone parabolic, which means we all know how the party will end for Cronos Group.

Ride Cronos Stock’s Meteoric Rise … Before You Can’t

By Nicolas Chahine, InvestorPlace Contributor
CRON is a hyper-momentum stock and there's no perfect time to buy it. Valuation aside, cannabis investing is young and the potential is great.
Load More